Dr Reddy’s to purchase Mayne Pharma’s US generic portfolio for $105 million
Dr. Reddy's introduced on Monday that it has agreed to purchase Mayne Pharma's US generic prescription product portfolio for $105 ...
Dr. Reddy's introduced on Monday that it has agreed to purchase Mayne Pharma's US generic prescription product portfolio for $105 ...
BENGALURU : Dr. Reddy’s Laboratories Ltd and Cipla Ltd beat Aurobindo Pharma to grow to be the nation’s second and ...
NEW DELHI : The NSE Pharma Index has rebounded virtually 9% from its lows in June. Whereas a number of ...
India is trying to leverage its pharmaceutical manufacturing to fill a medication provide hole in Russia that has been hit ...
The US Meals and Drug Administration (USFDA) has determined to restart an outdated pilot undertaking, conducting shock inspections of international ...
Although much less recognized, India can also be well-known for its top quality and low-cost medicines. As per knowledge from ...
NEW DELHI: Right here is the checklist of high 10 shares which might be prone to be in concentrate on ...
After a comparatively delicate first quarter, Dr Reddy’s Laboratories Ltd reported robust efficiency in the course of the September quarter, ...
The Indian pharma market (IPM) continued to see healthy double-digit growth of 12.4% year-on-year in September. The growth rate however ...
[mc4wp_form id=”158″]
© 2021 Success News - Developed by Sawah Web.
© 2021 Success News - Developed by Sawah Web.